PIN35 COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS INFECTION IN HIGH-RISK INFANTS IN JAPAN
May 1, 2007, 00:00 AM
10.1016/S1098-3015(10)69055-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)69055-9/fulltext
Section Title :
Section Order :
250
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)69055-9&doi=10.1016/S1098-3015(10)69055-9